Clinica Baviera (Spain) Probability of Future Stock Price Finishing Over 36.39
| CBAV Stock | EUR 33.90 0.40 1.19% |
Clinica |
Clinica Baviera Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clinica Baviera for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clinica Baviera can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Clinica Baviera has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Clinica Baviera has accumulated 6.52 M in total debt with debt to equity ratio (D/E) of 154.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clinica Baviera has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Clinica Baviera until it has trouble settling it off, either with new capital or with free cash flow. So, Clinica Baviera's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Clinica Baviera sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Clinica to invest in growth at high rates of return. When we think about Clinica Baviera's use of debt, we should always consider it together with cash and equity. | |
| About 92.0% of Clinica Baviera shares are held by company insiders |
Clinica Baviera Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Clinica Stock often depends not only on the future outlook of the current and potential Clinica Baviera's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clinica Baviera's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.3 M | |
| Cash And Short Term Investments | 32.3 M |
Clinica Baviera Technical Analysis
Clinica Baviera's future price can be derived by breaking down and analyzing its technical indicators over time. Clinica Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Clinica Baviera. In general, you should focus on analyzing Clinica Stock price patterns and their correlations with different microeconomic environments and drivers.
Clinica Baviera Predictive Forecast Models
Clinica Baviera's time-series forecasting models is one of many Clinica Baviera's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Clinica Baviera's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Clinica Baviera
Checking the ongoing alerts about Clinica Baviera for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Clinica Baviera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Clinica Baviera has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Clinica Baviera has accumulated 6.52 M in total debt with debt to equity ratio (D/E) of 154.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clinica Baviera has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Clinica Baviera until it has trouble settling it off, either with new capital or with free cash flow. So, Clinica Baviera's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Clinica Baviera sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Clinica to invest in growth at high rates of return. When we think about Clinica Baviera's use of debt, we should always consider it together with cash and equity. | |
| About 92.0% of Clinica Baviera shares are held by company insiders |
Other Information on Investing in Clinica Stock
Clinica Baviera financial ratios help investors to determine whether Clinica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clinica with respect to the benefits of owning Clinica Baviera security.